Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Not applicableStudy completedNCT06086665
What this trial is testing

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Asan Medical Center 850
Testing effectiveness (Phase 2)Study completedNCT00325351
What this trial is testing

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Bayer 45
Testing effectiveness (Phase 2)Study completedNCT02312245
What this trial is testing

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Mayo Clinic 13
Testing effectiveness (Phase 2)Looking for participantsNCT06434610
What this trial is testing

B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Shanghai Jiaolian Drug Research and Development Co., Ltd 90
Large-scale testing (Phase 3)Study completedNCT03863860
What this trial is testing

A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 252
Testing effectiveness (Phase 2)Study completedNCT02659384
What this trial is testing

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
European Organisation for Research and Treatment of Cancer - EORTC 122
Large-scale testing (Phase 3)Study completedNCT03398655
What this trial is testing

VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
Vascular Biogenics Ltd. operating as VBL Therapeutics 408
Testing effectiveness (Phase 2)UnknownNCT06243185
What this trial is testing

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Who this might be right for
Recurrent Ovarian Carcinoma
Fengzhi Feng 30
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00025155
What this trial is testing

Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT05258747
What this trial is testing

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Sandoz 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02571725
What this trial is testing

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
New Mexico Cancer Research Alliance 50
Early research (Phase 1)Study completedNCT03732768
What this trial is testing

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisOvarian Cancer
Oncoinvent Solutions AS 21
Testing effectiveness (Phase 2)Looking for participantsNCT05551208
What this trial is testing

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Who this might be right for
Ovarian Cancer
Chongqing University Cancer Hospital 42
Not applicableWithdrawnNCT00551265
What this trial is testing

Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)UnknownNCT04720807
What this trial is testing

Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Not applicableEnded earlyNCT01144442
What this trial is testing

WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
Masonic Cancer Center, University of Minnesota 10
Early research (Phase 1)Study completedNCT00066456
What this trial is testing

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group 13
Testing effectiveness (Phase 2)UnknownNCT06241105
What this trial is testing

Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Carcinoma
Peking Union Medical College Hospital 69
Next Page